<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-SWTK82SU</identifier><date>2021</date><creator>Kozjek, Eva</creator><creator>Trampuš-Bakija, Alenka</creator><relation>documents/doc/S/URN_NBN_SI_doc-SWTK82SU_001.pdf</relation><relation>documents/doc/S/URN_NBN_SI_doc-SWTK82SU_001.txt</relation><format format_type="issue">3</format><format format_type="type">article</format><format format_type="extent">str. 68-75</format><identifier identifier_type="ISSN">2670-4463</identifier><identifier identifier_type="COBISSID">91572739</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-SWTK82SU</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko združenje za klinično kemijo in laboratorijsko medicino</publisher><source>Laboratorijska medicina</source><rights>InC</rights><subject language_type_id="slv">akutna limfoblastna levkemija</subject><subject language_type_id="slv">asparginaza</subject><subject language_type_id="slv">encimska aktivnost</subject><subject language_type_id="slv">pediatrija</subject><subject language_type_id="slv">tiha inaktivacija</subject><title>Optimizacija postopka za določitev aktivnosti asparaginaze pri bolnikih z akutno limfoblastno levkemijo</title><title>Optimisation of asparginase activity assay in patients with acute lymphoblastic leukemia</title></Record>